SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-176510
Filing Date
2022-06-17
Accepted
2022-06-17 16:11:12
Documents
12
Period of Report
2022-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d326312d8k.htm   iXBRL 8-K 35058
  Complete submission text file 0001193125-22-176510.txt   157335

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rna-20220615.xsd EX-101.SCH 2888
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20220615_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20220615_pre.xml EX-101.PRE 11284
6 EXTRACTED XBRL INSTANCE DOCUMENT d326312d8k_htm.xml XML 3361
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 221023911
SIC: 2834 Pharmaceutical Preparations